Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MARCH7 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | FCRLA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | OR9A2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | CABP4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | AHSP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | LDLRAD3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | TUBB1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | SLC15A3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | CTXN3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | TRAPPC11 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |